Literature DB >> 5332176

Thalassemia: the consequences of unbalanced hemoglobin synthesis.

D G Nathan, R B Gunn.   

Abstract

Entities:  

Mesh:

Year:  1966        PMID: 5332176     DOI: 10.1016/0002-9343(66)90039-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  47 in total

1.  Identification of an erythroid-enriched endoribonuclease activity involved in specific mRNA cleavage.

Authors:  Z Wang; M Kiledjian
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

2.  The poly(A)-binding protein and an mRNA stability protein jointly regulate an endoribonuclease activity.

Authors:  Z Wang; M Kiledjian
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  2003 William Allan Award address. The Thalassemias: the role of molecular genetics in an evolving global health problem.

Authors:  David Weatherall
Journal:  Am J Hum Genet       Date:  2004-03       Impact factor: 11.025

Review 4.  Thalassemia: genotypes and phenotypes.

Authors:  D Loukopoulos
Journal:  Ann Hematol       Date:  1991-05       Impact factor: 3.673

Review 5.  Thalassemia: genotypes and phenotypes.

Authors:  D Loukopoulos
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

6.  2006 Association of American Physicians George M. Kober Medal. Introduction of David G. Nathan, MD.

Authors:  Edward J Benz
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

7.  The thalassemias and related disorders.

Authors:  Alain J Marengo-Rowe
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-01

8.  A monoclonal antibody-linked immunoassay for hemoglobin H disease.

Authors:  M Shyamala; C R Kiefer; H Moscoso; F A Garver
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

Review 9.  Chaperoning erythropoiesis.

Authors:  Mitchell J Weiss; Camila O dos Santos
Journal:  Blood       Date:  2008-12-24       Impact factor: 22.113

10.  Pathogenesis of hemolytic anemia in homozygous hemoglobin C disease.

Authors:  S Charache; C L Conley; D F Waugh; R J Ugoretz; J R Spurrell
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.